Hand, foot, and mouth disease (HFMD) is a viral and febrile disease frequently seen in children, generally presenting with a mild course and accompanied by oral rash and rashes on palmar surfaces of hand and feet (Kliegman and Geme 2015). Cases of HFMD are seen all over the world; however, epidemics with serious complications that result in deaths are reported mostly from Western Pacific Region countries (WHO 2011).
CV-A6 was identified, for the first time, as the causative agent for HFMD in an epidemic that emerged in Finland in 2008 (Österback et al. 2009). Following this, the identification of CV-A6 as the major causative agent for HFMD epidemics continued to occur in France, Spain and other European countries in 2009–2011 (Bracho et al. 2011; Mirand et al. 2012). HFMD epidemics caused by CV-A6 were also reported in the Western Pacific Region and the Americas after 2009 (CDC 2012; Chen et al. 2012; Fujimoto et al. 2012; Fonseca et al. 2014; Han et al. 2014; Hu et al. 2015). More severe clinical course and widespread skin rashes were seen in cases caused by CV-A6, different from typical HFMD (Romero 2017).
Cases with no severe clinical course can be diagnosed with clinical findings without the need for microbiological diagnostic tests. However, certain serotypes may lead to severe disease (Romero 2017). Serotypes may vary within and among countries. Therefore, determination of the causative serotype is important for public health as well as for the design and implementation of the preventive measures. Recent increases in movements of people between countries and continents could be influential in the spread of different viral serotypes. Full identification of the causative organism could also provide information for the vaccine development studies in addition to its epidemiological importance (WHO 2011).
The published research on HFMD in Turkey has been generally towards the clinical aspects of the disease (Ekinci et al. 2013; Demirhan et al. 2016; Bucak et al. 2017). Apart from a single case study, no detailed investigations on the viral agent itself have been conducted (Kiratli et al. 2017). In this investigation, we aimed to determine the serotype distribution in HFMD cases in children.
Primers used for PCR.
Target Serotype | Orientation | Sequence |
---|---|---|
Pan-EV-5’UTR Outer | Forward | 5’-CYTTGTGCGCCTGTTTT-3’ |
Reverse | 5’-ATTGTCACCATAAGCAGCC-3’ | |
Pan-EV-5’UTR-Inner | Forward | 5’-CAAGYACTTCTGTMWCCCC-3’ |
Reverse | 5’-CCCAAAGTAGTCGGTTCC-3’ | |
EV-A71-VP1 | Forward | 5’-AGAGCATGATTGAGACACG-3’ |
Reverse | 5’-RTCTTTCTCYTGTTTGTGTTC-3’ | |
CV-A16-VP1 | Forward | 5’-TGCAGACATGATTGACCAG-3’ |
Reverse | 5’-TGCCTACAGTTCTGATGCTA-3’ |
The amplification products and the 100 bp marker were loaded into 1.5% agarose gel, electrophoresed for 40 minutes under 80 V, and analyzed in Molecular Imager Gel Doc XR System (BioRad, Hercules, CA, U.S.A.) imaging device.
The sequences of PCR products were assembled and edited using BioEdit version 7.0.5 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). This sequence was compared with the sequences deposited in GenBank of the National Center for Biotechnology Information (NCBI) by means of the BLASTN 2.2.19 option. The consensus sequence was compiled in a FASTA file for the phylogenetic analysis and aligned with the Clustal W 1.8.1. profile mode included in the Mega 4.0.2 (https://www.megasoftware.net/mega4/) software.
Eleven of 27 children included in the study were female and 16 were male. The ages ranged from 4 months to 9 years, and 21 of the 27 children were aged between 1 and 3 years (78%). Eighteen of the patients (67%) applied to the hospital during the summer months. In the cohorts, neither systemic blisters nor high fever was noted. None of our patients needed hospitalization. There were no severe complications such as meningitis and encephalitis. Only three of 27 patients applied to the hospital with nail shedding after the recovery period of approximately six weeks.
A total of 27 patient samples, 15 from the 2015–2016 season and 12 from 2017, were included in the study. The nested PCR results of 12 patients, sampled in 2015–2016, revealed products with a length of 530 and 389 bp (Fig. 4 and 5) that corresponded to the pan-enterovirus outer and inner primers, respectively. This finding was interpreted as proof of the
Phylogenetic identities of the coxsackievirus A isolates, based on VP1 sequences.
Isolate code | Primer | Nearest phylogenetic neighbours | Identity percentage |
---|---|---|---|
HFM-2 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-5 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-9 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-10 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-11 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-12 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-14 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-15 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM-16 | 153 F/541 R | Coxsackievirus A6 | 99% |
HFM24 | 153 F/541 R | Coxsackievirus A16 | 99% |
HFM25 | 153 F/541 R | Coxsackievirus A16 | 99% |
HFM26 | 153 F/541 R | Coxsackievirus A16 | 97% |
Twelve patient samples from 2017, were amplified by PCR and seven samples were positive for
All the samples were inoculated into the Vero E6 cell line and characteristic cytopathic effects were noticed after 3-days incubation. The supernatant samples were collected and the PCR test was carried out with pan-enterovirus primers (data not shown). It was noticed that the results were compatible with the PCR performed directly from the patient samples.
Hand, foot, and mouth disease epidemics are mostly caused by EV-A71 and CV-A16. Recently, CV-A6 has been identified as the agent of epidemics causing severe forms of the disease with general skin involvement. Similar epidemics that started in Finland in 2008 were also reported from Singapore in 2009, France and Taiwan in 2010, and the USA, Cuba, Spain, Japan, and China in 2011 (Bian et al. 2015). In this study, CV-A6 was found to be the causative agent in 75% of the cases what was confirmed by sequencing (Table III). This result is consistent with the current literature that reports an increase in CV-A6 incidence (Bian et al. 2015). HFMD is not a mandatory disease to report to public health authorities in Turkey. Therefore, complete data on the causative agents of the cases throughout the country is not yet known. Only a single case study identifying the causative agent was reported from Turkey (Kiratli et al. 2017). In that study, the identification of CV-16 in a 39 years old male patient was performed. The present study identified CV-A16 in 25% of the pediatric samples (Table III). A study conducted in China between 2011 and 2015 on 2130 samples positive for
The patients’ samples and their positivity for coxsackievirus A6 and A16.
Year | No. of samples | Coxsackievirus A6 positivity | Coxsackievirus A16 positivity | |
---|---|---|---|---|
2015–2016 | 15 | 12 | 9 | 0 |
2017 | 12 | 7 | 0 | 3 |
Total | 27 | 19 | 9 | 3 |
The frequency of HFMD emergences peak twice in a year in countries with a tropical climate; however, it can be observed throughout the year. It exhibits a single annual rise in summer or fall in countries located at higher latitudes (Blomqvist et al. 2010; Huang et al. 2015; Wang et al. 2017). In Turkey, individual studies showed that the frequency of HFMD rises during summer (Topkarcı 2013; Uğraş et al. 2014; Yorulmaz and Onat 2017). In parallel with the previous research, in the present study, it has been observed that the majority of HFMD cases (67%) applied to our hospital during summer months.
Hand, foot, and mouth disease frequently affects children under the age of 5. Previous studies show that more than half of the individuals affected by epidemics were aged between 1 and 3 years (Montes et al. 2013; Huang et al. 2015). Seventy-eight percent of 27 children included in the current study was aged between 1 and 3 years. Epidemiological studies investigating HFMD have shown that the incidence is 1.5–2 times higher among boys compared to girls (Huang et al. 2015; Sun et al. 2017). In this study, similarly, the ratio of boys/girls was 16/11.
One of the limitations of the current study is that our cohorts were from a single city and the numbers of the patient were rather small. Therefore, our result might not reflect the overall HFMD epidemiology of all country. Secondly, only 12 sequencing results could be used to make the evolutionary trees to establish the relationship of the CV-A6, or CV-A16 in Turkey in relation to others in the world. Therefore further studies including samples from various regions of Turkey with a larger sampling might shed a better light on the dissemination as well as the phylogenetic relationships of these viral agents. Nevertheless, the data presented in the current study reports for the first time a detailed investigation about the presence of previously unnoticed serotypes on an important public health agent.
Geographically, Turkey acts as a gateway between Asia and Europe, and receives an influx of tourists from various countries across the world during summer months, the time that the incidence of HFMD peaks. Therefore, the establishment of a national surveillance system for HFMD and identification of causative serotype agents are important from an epidemiological point of view as well as for the planning and execution of preventive measures including vaccination. Our investigation and reporting might be useful in guiding these efforts.